Novel Insights into the Mechanisms Regulating Pro-Atrial Natriuretic Peptide Cleavage in the Heart and Blood Pressure Regulation: Proprotein Convertase Subtilisin/Kexin 6 Is the Corin Activating Enzyme

Circulation Research

Volumn 118, Issue 2, 2016, Pages 196-198

  Volpe, Massimo ^a   Rubattu, Speranza ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CORIN PROTEIN, HUMAN; CORIN PROTEIN, MOUSE; PCSK6 PROTEIN, HUMAN; PCSK6 PROTEIN, MOUSE; PROTEIN PRECURSOR; SERINE PROTEINASE;

ANIMAL; BLOOD PRESSURE; CARDIAC MUSCLE; CELL LINE; DEFICIENCY; ENZYME ACTIVATION; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HUMAN; HYPERTENSION; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CELL LINE; ENZYME ACTIVATION; HUMANS; HYPERTENSION; MICE; MICE, KNOCKOUT; MYOCARDIUM; PROPROTEIN CONVERTASES; PROTEIN PRECURSORS; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84955305295     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.307875     Document Type: Review

References (15)

1. Volpe M, Rubattu S, Burnett J Jr., Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J 2014;35:419-425. doi: 10.1093/eurheartj/eht466.
2. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O., Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995;267:679-681
3. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N., Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 1997;94:14730-14735
4. Rubattu S, Sciarretta S, Volpe M., Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases. Clin Sci (Lond) 2014;127:1 13. doi: 10.1042/CS20130427.
5. Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC Jr., Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics. Eur Heart J 2013-34 886 893c. doi: 10.1093/eurheartj/ehs262.
6. Yan W, Wu F, Morser J, Wu Q., Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci USA 2000;97:8525-8529. doi: 10.1073/pnas.150149097.
7. Chan JC, Knudson O, Wu F, Morser J, Dole WP, Wu Q., Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci USA 2005;102:785-790. doi: 10.1073/pnas.0407234102.
8. Gladysheva IP, Wang D, McNamee RA, Houng AK, Mohamad AA, Fan TM, Reed GL., Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy. Hypertension 2013;61:327-332. doi: 10.1161/HYPERTENSIONAHA.112.193631.
9. Chen S, Cao P, Dong N, Peng J, Zhang C, Wang H, Zhou T, Yang J, Zhang Y, Martelli EE, Naga Prasad SV, Miller RE, Malfait AM, Zhou Y, Wu Q., PCSK6-mediated corin activation is essential for normal blood pressure. Nat Med 2015;21:1048-1053. doi: 10.1038/nm.3920.
10. Wang W, Liao X, Fukuda K, Knappe S, Wu F, Dries DL, Qin J, Wu Q., Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ Res 2008;103:502-508. doi: 10.1161/CIRCRESAHA.108.177352.
11. Calvieri C, Rubattu S, Volpe M., Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. J Mol Med (Berl) 2012;90:5 13. doi: 10.1007/s00109-011-0801-z.
12. Dries DL, Victor RG, Rame JE, Cooper RS, Wu X, Zhu X, Leonard D, Ho SI, Wu Q, Post W, Drazner MH., Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 2005;112:2403-2410. doi: 10.1161/CIRCULATIONAHA.105.568881.
13. Turpeinen H, Ortutay Z, Pesu M., Genetics of the first seven proprotein convertase enzymes in health and disease. Curr Genomics 2013;14:453-467. doi: 10.2174/1389202911314050010.
14. Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D'Agostino RB Sr, Kubica J, Volpe M, Agewall S, Kereiakes DJ, Kelm M., Effects of Proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis. Ann Intern Med 2015;163:40-51. doi: 10.7326/M14-2957.
15. Volpe M., Natriuretic peptides and cardio-renal disease. Int J Cardiol 2014;176:630-639. doi: 10.1016/j.ijcard.2014.08.032.